10 April 2026
Dr. Tal Raviv is among the first surgeons in the United States to implant the PureSee™ intraocular lens (IOL), a next-generation extended depth-of-focus (EDOF) lens that delivers crisp, high-quality vision with minimal visual disturbances.
Why PureSee™ is in High Demand
Approved by the FDA in March 2026, PureSee™ is revolutionizing cataract and refractive lens exchange (RLE) surgery. With its remarkable ability to restore vision across a wide range, PureSee™ is quickly becoming the lens of choice for those seeking superior vision quality in all lighting conditions. Due to its proven effectiveness and comfort, we anticipate significant demand and have already seen a surge in patients opting for this advanced lens.
A More Natural Range of Vision
PureSee is designed to restore vision across a functional range. Patients can typically expect:
- Clear distance vision for driving and daily activities
- Strong intermediate vision for computers, dashboards, and cooking
- Reduced dependence on glasses for most tasks
Unlike traditional monofocal lenses, which focus at a single distance, PureSee extends usable vision while maintaining a sharp, natural visual experience.
What Makes PureSee Different
PureSee is the first FDA-approved Extended Depth of Focus (EDOF) intraocular lens (IOL) that does not come with a warning about reduced contrast sensitivity. This is important because contrast sensitivity significantly affects how clearly you can see in low-light or high-contrast situations.
Contrast sensitivity is crucial for:
- Night driving
- Reading in dim lighting
- Recognizing faces and fine details
By maintaining a contrast comparable to that of a traditional monofocal lens, PureSee offers a level of visual clarity that feels more natural.
Additionally, PureSee’s purely refractive optical design helps minimize unwanted effects such as halos and glare. In clinical studies submitted for FDA review:
- 97% of patients reported no very bothersome visual disturbances
- The vast majority said they would recommend the lens to others
Although newly approved in the United States, the lens has already been implanted in hundreds of thousands of eyes internationally. This global track record—combined with FDA-reviewed clinical data—offers added confidence as the lens becomes more widely available in the U.S.
What to Expect After Surgery
Most patients who choose PureSee experience:
- Clear vision for distance and intermediate activities without glasses
- Improved visual comfort in a variety of lighting conditions
- A smooth recovery consistent with modern cataract surgery
For fine print or prolonged reading, light readers are typically still helpful. As with all premium lens options, a small percentage of patients may benefit from a minor laser enhancement procedure after healing to refine results further.
Customized. Modernized. Simplified. Now Available at Eye Center of New York
At the Eye Center of New York, we have seen strong early demand, with many patients choosing this lens for its balance of clarity, range, and visual comfort. As one of the first practices in the region to offer PureSee, we are proud to bring this technology to patients seeking a more refined visual outcome.
During your consultation, Dr. Raviv will guide you through all available options—including monofocal, EDOF, multifocal, and adjustable lenses—to determine what best aligns with your anatomy, lifestyle, and expectations.
If you are considering cataract surgery or refractive lens exchange, PureSee may offer a compelling path toward clearer, more comfortable vision. Schedule your evaluation at the Eye Center of New York today.
